Skip to Main Content

Author Details

Maria Tsoli
2003
36
19
PMIDPaper TitleJournal TitlePublished Year
37480151Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.Cell Biosci2023
38001908From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients.2023
37683275Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas.2023
37001527Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.Cancer Cell2023
36937401<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma.Front Oncol2023
37523146High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer.Cancer Res2023
35802025FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.Cancer Res2022
35832071Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.Theranostics2022
34944870Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.Cancers2021
33805713Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine Glioma.Cancers2021
33852836Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.Cell Rep2021
33579942Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.Nat Commun2021
34458732Parents' experiences of postmortem tumor donation for high-grade gliomas: benefits and suggested improvements.Neuro-Oncology Advances2021
31398252Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas.Neuro Oncol2020
32238360Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.Cancer Discov2020
30808815Predictors of Success of Phase II Pediatric Oncology Clinical Trials.Oncologist2019
30446898International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma.J Neurooncol2019
30484110Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma.J Neurooncol2019
31235425Translating palbociclib to the clinic for DIPG - What is truly achievable?eBioMedicine2019
29484131Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.Oncotarget2018
30220707Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.Br J Cancer2018
30299205Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.Cancer Biol Ther2018
28052119Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.PLoS ONE2017
28401062Genomic Insights into Diffuse Intrinsic Pontine Glioma.Frontiers in Oncology2017
26529279Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.Seminars in Cell and Developmental Biology2016
25043816A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.Cell Metab2014
24667661Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation.PLoS ONE2014
23201432Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem.Trends in Endocrinology and Metabolism2013
22361433Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.Aging2012
22719069Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice.Cancer Research2012
23012247Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.Mol Cancer Ther2012
20167946Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.Mol Cell Proteomics2011
20060928The alternatively spliced murine pregnane X receptor isoform, mPXR(delta171-211) exhibits a repressive action.International Journal of Biochemistry and Cell Biology2010
17188925Pregnane X receptor: promiscuous regulator of detoxification pathways.International Journal of Biochemistry and Cell Biology2007
17193536Cellular uptake and toxicity of Au55 clusters.Small2005
12833340Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires.Angewandte Chemie - International Edition2003
  • 1 - 36 of 36

Recommended Authors

Collaborators

Co-authored papers 24
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 8
School of Clinical Medicine
Co-authored papers 6
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Lowy Cancer Research Centre, Children's Cancer Institute
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Perth Children's Hospital
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 2
Co-authored papers 2
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Co-authored papers 2